Related Experiment Video

Updated: Aug 21, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Recent advances in the secondary prevention of coronary heart disease

Angie Veverka1, Jamie L Jolly

  • 1Wingate University School of Pharmacy, Campus Box 3087, Wingate, NC 28174 0157, USA. aveverka@wingate.edu.

Expert Review of Cardiovascular Therapy
|October 27, 2004
PubMed

Insights

This review examines controversial topics in secondary prevention of coronary heart disease, including the use of angiotensin antagonists, statins, and cholesterol-targeting therapies in specific patient groups.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Background:

  • Current guidelines exist for secondary prevention of coronary heart disease.
  • Recent clinical trials necessitate a re-evaluation of established practices.
  • Controversial issues require further clarification for optimal patient care.

Purpose of the Study:

  • To review and discuss controversial aspects of secondary prevention in coronary heart disease.
  • To analyze the latest evidence regarding specific therapeutic interventions.
  • To provide insights into ongoing debates in cardiovascular disease management.

Main Methods:

  • Literature review of recent clinical trials and practice guidelines.
  • Analysis of evidence concerning angiotensin and aldosterone antagonists post-myocardial infarction.
  • Evaluation of angiotensin-converting enzyme inhibitors in stable coronary heart disease with preserved ejection fraction.
  • Assessment of high-intensity low-density lipoprotein cholesterol lowering strategies.
  • Review of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitor use in the elderly.
  • Examination of high-density lipoprotein cholesterol targeting with niacin.

Main Results:

  • Evidence regarding the role of angiotensin and aldosterone antagonists post-myocardial infarction is debated.
  • The benefit of angiotensin-converting enzyme inhibitors in specific patient subgroups remains a discussion point.
  • Optimal intensity for low-density lipoprotein cholesterol lowering requires further definition.
  • The efficacy and safety of statins in elderly populations warrant continued investigation.
  • Targeting high-density lipoprotein cholesterol with niacin presents complex outcomes.

Conclusions:

  • The secondary prevention of coronary heart disease involves several areas of ongoing clinical debate.
  • Further research and guideline refinement are needed for controversial therapeutic strategies.
  • Personalized approaches to cardiovascular disease management are crucial.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...